Literature DB >> 7739764

Regional alterations of thiamine phosphate esters and of thiamine diphosphate-dependent enzymes in relation to function in experimental Wernicke's encephalopathy.

M Héroux1, R F Butterworth.   

Abstract

Thiamine phosphate esters (thiamine monophosphate-TMP; thiamine diphosphate-TDP and thiamine triphosphate-TTP) were measured as their thiochrome derivatives by High Performance Liquid Chromatography in the brains of pyrithiamine-treated rats at various stages during the development of thiamine deficiency encephalopathy. Severe encephalopathy was accompanied by significant reductions of all three thiamine phosphate esters in brain. Neurological symptoms of thiamine deficiency appeared when brain levels of TMP and TDP fell below 15% of normal values. Activities of the TDP-dependent enzyme alpha-ketoglutarate dehydrogenase were more severely reduced in thalamus compared to cerebral cortex, a less vulnerable brain structure. On the other hand, reductions of TTP, the non-cofactor form of thiamine, occurred to a greater extent in cerebral cortex than thalamus. Early reductions of TDP-dependent enzymes and the ensuing metabolic pertubations such as lactic acidosis impaired brain energy metabolism, and NMDA-receptor mediated excitotoxicity offer rational explanations for the selective vulnerability of brain structures such as thalamus to the deleterious effects of thiamine deficiency.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7739764     DOI: 10.1007/bf00995157

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  31 in total

1.  Decreased metabolism in vivo of glucose into amino acids of the brain of thiamine-deficient rats after treatment with pyrithiamine.

Authors:  M K Gaitonde; N A Fayein; A L Johnson
Journal:  J Neurochem       Date:  1975-06       Impact factor: 5.372

2.  Uptake of pyrithiamine by tissue of rats.

Authors:  G RINDI; V PERRI
Journal:  Biochem J       Date:  1961-07       Impact factor: 3.857

3.  The induction and reversibility of cerebral acidosis in thiamine deficiency.

Authors:  A M Hakim
Journal:  Ann Neurol       Date:  1984-12       Impact factor: 10.422

4.  Analysis of thiamine and its phosphate esters by high-performance liquid chromatography.

Authors:  K Ishii; K Sarai; H Sanemori; T Kawasaki
Journal:  Anal Biochem       Date:  1979-08       Impact factor: 3.365

Review 5.  Effects of thiamine deficiency on brain metabolism: implications for the pathogenesis of the Wernicke-Korsakoff syndrome.

Authors:  R F Butterworth
Journal:  Alcohol Alcohol       Date:  1989       Impact factor: 2.826

6.  Low energy levels in thiamine-deficient encephalopathy.

Authors:  H Aikawa; I S Watanabe; T Furuse; Y Iwasaki; E Satoyoshi; T Sumi; T Moroji
Journal:  J Neuropathol Exp Neurol       Date:  1984-05       Impact factor: 3.685

7.  Correlation of enzymatic, metabolic, and behavioral deficits in thiamin deficiency and its reversal.

Authors:  G E Gibson; H Ksiezak-Reding; K F Sheu; V Mykytyn; J P Blass
Journal:  Neurochem Res       Date:  1984-06       Impact factor: 3.996

8.  Activities of thiamine-dependent enzymes in two experimental models of thiamine deficiency encephalopathy: 3. Transketolase.

Authors:  J F Giguère; R F Butterworth
Journal:  Neurochem Res       Date:  1987-03       Impact factor: 3.996

9.  Model of Wernicke's encephalopathy.

Authors:  J C Troncoso; M V Johnston; K M Hess; J W Griffin; D L Price
Journal:  Arch Neurol       Date:  1981-06

10.  Extracellular glutamate is increased in thalamus during thiamine deficiency-induced lesions and is blocked by MK-801.

Authors:  P J Langlais; S X Zhang
Journal:  J Neurochem       Date:  1993-12       Impact factor: 5.372

View more
  13 in total

Review 1.  Alpha-ketoglutarate dehydrogenase: a target and generator of oxidative stress.

Authors:  Laszlo Tretter; Vera Adam-Vizi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-12-29       Impact factor: 6.237

Review 2.  The blood-brain barrier and selective vulnerability in experimental thiamine-deficiency encephalopathy in the mouse.

Authors:  N Harata; Y Iwasaki
Journal:  Metab Brain Dis       Date:  1996-03       Impact factor: 3.584

Review 3.  Neuropathology of thiamine deficiency: an update on the comparative analysis of human disorders and experimental models.

Authors:  P J Langlais; S X Zhang; L M Savage
Journal:  Metab Brain Dis       Date:  1996-03       Impact factor: 3.584

Review 4.  Mechanisms of neuronal cell death in Wernicke's encephalopathy.

Authors:  A S Hazell; K G Todd; R F Butterworth
Journal:  Metab Brain Dis       Date:  1998-06       Impact factor: 3.584

5.  Can megadoses of thiamine prevent ethanol-induced damages of rat hippocampal CA1 pyramidal neurones?

Authors:  S Wenisch; T Steinmetz; B Fortmann; R Leiser; I Bitsch
Journal:  Z Ernahrungswiss       Date:  1996-09

Review 6.  Role of mitochondrial dysfunction and oxidative stress in the pathogenesis of selective neuronal loss in Wernicke's encephalopathy.

Authors:  Paul Desjardins; Roger F Butterworth
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

Review 7.  Brain and behavioral pathology in an animal model of Wernicke's encephalopathy and Wernicke-Korsakoff Syndrome.

Authors:  Ryan P Vetreno; Raddy L Ramos; Steven Anzalone; Lisa M Savage
Journal:  Brain Res       Date:  2011-11-28       Impact factor: 3.252

Review 8.  Neuronal cell death in Wernicke's encephalopathy: pathophysiologic mechanisms and implications for PET imaging.

Authors:  D K Leong; R F Butterworth
Journal:  Metab Brain Dis       Date:  1996-03       Impact factor: 3.584

9.  In vivo evidence for alcohol-induced neurochemical changes in rat brain without protracted withdrawal, pronounced thiamine deficiency, or severe liver damage.

Authors:  Natalie M Zahr; Dirk Mayer; Shara Vinco; Juan Orduna; Richard Luong; Edith V Sullivan; Adolf Pfefferbaum
Journal:  Neuropsychopharmacology       Date:  2008-08-13       Impact factor: 7.853

10.  Selective increase of neuronal cyclooxygenase-2 (COX-2) expression in vulnerable brain regions of rats with experimental Wernicke's encephalopathy: effect of nimesulide.

Authors:  Baoying Gu; Paul Desjardins; Roger F Butterworth
Journal:  Metab Brain Dis       Date:  2008-05-15       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.